Results 221 to 230 of about 5,154 (256)

Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation. [PDF]

Purinergic Signal
Kiaie SH, Hatami Z, Nasr MS, Pazooki P, Hemmati S, Baradaran B, Valizadeh H.   +6 more
europepmc   +1 more source

Corrigendum: TLR2 activation by Porphyromonas gingivalis requires both PPAD activity and fimbriae

Aleksandra Wielento, Grzegorz Bereta, Katarzyna B. Łagosz-Ćwik, Sigrun Eick, Richard J. Lamont, Aleksander M. Grabiec, Jan Potempa   +6 more
openalex   +1 more source

Neuroendocrine cells initiate protective upper airway reflexes. [PDF]

Science
Seeholzer LF, Julius D.
europepmc   +1 more source

AVPV Kiss1 neuron-specific knockdown of purinergic P2X2 receptor suppresses LH surge and ovulation in Kiss1-Cre rats. [PDF]

J Reprod Dev
Hazim S, Seki S, Yabushita R, Nagae M, Tsuchida H, Hirabayashi M, Uenoyama Y, Tsukamura H, Inoue N.   +8 more
europepmc   +1 more source

Ventilator-associated Brain Injury: A New Priority for Research in Mechanical Ventilation. [PDF]

Am J Respir Crit Care Med
Bassi T, Taran S, Girard TD, Robba C, Goligher EC.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

PPADS: Physician-PArent Decision-Support for Neonatal Intensive Care

Medinfo, 2013
Family-centered care is becoming the new standard for Neonatal Intensive Care Unit (NICU) patients. In support of this, we developed the Physician PArent Decision Support System (PPADS), which provides clinical updates and predictions of clinical ...
M. Frize, E. Bariciak, Jeff Gilchrist
semanticscholar   +3 more sources

PPADS is a reversible competitive antagonist of the NAADP receptor.

Cell Calcium, 2007
NAADP has been shown to act as a second messenger in a wide range of systems from plants to mammalian cells. Although it had always been considered as a canonical second messenger, recent work has shown that it is also active when applied extracellularly.
R. Billington, A. Genazzani
semanticscholar   +5 more sources

PPAD: A tool for presumption of atopic dermatitis [PDF]

The Journal of Dermatology, 2011
AbstractAlthough it is a frequent disease, atopic dermatitis is poorly recognised and therefore under‐diagnosed. The aim of this study was to define and validate a convenient tool allowing presumption of atopic dermatitis for non‐dermatologists. A 20‐item questionnaire (PPAD) and an 8‐item short version (PPAD‐S) were developed in French by a board of ...
Misery, Laurent, Ortonne, Jean-Paul, Cambazard, Frédéric, Guillet, Gérard, Thomas, Luc, Lorette, Gérard, Durosier, Vincent, Rahhali, Nora, Auges, Marie, Taieb, Charles   +9 more
openaire   +4 more sources

PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.

European Journal of Pharmacology, 1992
We have characterized PPADS (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid) as a novel antagonist which selectively blocks P2 purinoceptor-mediated responses in rabbit vas deferens at pre- and postjunctional sites. PPADS did not interact with alpha 1-adrenoceptors, muscarinic M2 and M3 receptors, histamine H1 and adenosine A1 receptors.
G. Lambrecht, T. Friebe, Ulrike Grimm, U. Windscheif, E. Bungardt, C. Hildebrandt, H. Bäumert, G. Spatz-Kümbel, E. Mutschler   +8 more
semanticscholar   +4 more sources

Effect of PPADS on P2X Receptor-Mediated Responses of Human Blood Vessels

Bulletin of Experimental Biology and Medicine, 2004
In vitro experiments showed that pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid almost completely suppressed contractile responses of the gallbladder artery to alpha,beta-methylene-ATP, while alpha,beta-methylene-ATP-induced contractions of the major subcutaneous vein of patients with varicose disease did not change under the effect of the ...
A. Ziganshin, B. Ziganshin, L. R. Giniyatova, R. K. Dzhordzhikiya   +3 more
semanticscholar   +4 more sources